LFA
Legacy Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Buy |
999
+7
| +0.7% | +$3.68K | 0.08% | 194 |
|
|
2025
Q1 | $629K | Buy |
992
+264
| +36% | +$167K | 0.11% | 164 |
|
|
2024
Q4 | $519K | Sell |
728
-166
| -19% | -$118K | 0.09% | 187 |
|
|
2024
Q3 | $940K | Buy |
894
+16
| +2% | +$16.8K | 0.16% | 104 |
|
|
2024
Q2 | $923K | Buy |
878
+69
| +9% | +$72.5K | 0.16% | 100 |
|
|
2024
Q1 | $779K | Buy |
809
+60
| +8% | +$57.7K | 0.14% | 120 |
|
|
2023
Q4 | $658K | Buy |
749
+81
| +12% | +$71.1K | 0.13% | 126 |
|
|
2023
Q3 | $550K | Buy |
668
+167
| +33% | +$137K | 0.11% | 124 |
|
|
2023
Q2 | $360K | Buy |
501
+46
| +10% | +$33.1K | 0.07% | 180 |
|
|
2023
Q1 | $374K | Buy |
455
+42
| +10% | +$34.5K | 0.08% | 160 |
|
|
2022
Q4 | $298K | Buy |
413
+8
| +2% | +$5.77K | 0.06% | 179 |
|
|
2022
Q3 | $279K | Sell |
405
-11
| -3% | -$7.58K | 0.07% | 166 |
|
|
2022
Q2 | $246K | Buy |
416
+2
| +0.5% | +$1.18K | 0.06% | 176 |
|
|
2022
Q1 | $289K | Buy |
414
+74
| +22% | +$51.7K | 0.07% | 167 |
|
|
2021
Q4 | $215K | Buy |
+340
| New | +$215K | 0.05% | 194 |
|
|
2019
Q2 | – | Sell |
-15
| Closed | -$6K | – | 720 |
|
|
2019
Q1 | $6K | Buy |
15
+10
| +200% | +$4K | ﹤0.01% | 744 |
|
|
2018
Q4 | $2K | Sell |
5
-9
| -64% | -$3.6K | ﹤0.01% | 849 |
|
|
2018
Q3 | $5K | Hold |
14
| – | – | ﹤0.01% | 698 |
|
|
2018
Q2 | $5K | Buy |
14
+8
| +133% | +$2.86K | ﹤0.01% | 706 |
|
|
2018
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 790 |
|
|
2017
Q4 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 751 |
|